Provectus Biopharmaceuticals Inc (PVCT) Stock Price, Quote, News & History

PVCTOTCQB
$0.0537
0.000360.67%
At close: Apr 22, 5:00 PM EST
Loading...

Key Statistics

Open
$0.05
Close
$0.05
Volume / Avg.
356.43K / 346.10K
Day Range
$0.05 - $0.05
52 Wk Range
0.04 - 0.11
Market Cap
$22.57M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

Recent Provectus Biopharmaceuticals Inc News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-3.33M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
3.09M
Free Cash Flow (TTM)
-3.33M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-238.99K

Valuation Metrics

Enterprise Value
$25.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-18.62%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.02

Company Debt

Total Debt
$2.85M
LT Debt
$23.62K
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$251.29K
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-$272.99K

Key Statistics

Open
$0.05
Close
$0.05
Volume / Avg.
356.43K / 346.10K
Day Range
$0.05 - $0.05
52 Wk Range
0.04 - 0.11
Market Cap
$22.57M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Pharmaceuticals
Provectus Biopharmaceuticals Inc is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases based on a class of bioactive synthetic small molecule halogenated xanthenes (HXs). Its flagship HX molecule is named...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Provectus (PVCT) stock?

A

You can purchase shares of Provectus (OTCQB:PVCT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Provectus (PVCT) competitors?

A

There are no as such competitors for Provectus.

Q

What is the forecast, or price target, for Provectus (PVCT) stock?

A

There is no analysis for Provectus to provide a consensus price target.

Q

What is the current price for Provectus (PVCT)?

A

The stock price for Provectus (OTCQB: PVCT) is $0.0537 last updated April 22, 2026 at 2:53 PM EDT.

Q

Does Provectus (PVCT) pay a dividend?

A

There are no upcoming dividends for Provectus.

Q

When is Provectus (OTCQB:PVCT) reporting earnings?

A

Provectus does not have any upcoming earnings scheduled.

Q

Is Provectus (PVCT) going to split?

A

There is no upcoming split for Provectus.

Q

What sector and industry does Provectus (PVCT) operate in?

A

Provectus is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.